exRNAdisease

Entry Detail

---



General Information

Database ID: exR0270287 RNA Name: hsa-miR-641 RNA Type: miRNA Chromosome: chr19 Starnd: - Coordinate: Start Site(bp): 40282603 End Site(bp): 40282626 External Links: hsa-miR-641

Disease Information

Disease Name: Multiple Sclerosis Disease Category: Nervous System Diseases MeSH ID: D009103 Type: Diseases Category/Nervous System Diseases Alias: Sclerosis, Multiple//Sclerosis, Disseminated//Disseminated Sclerosis//MS (Multiple Sclerosis)//Multiple Sclerosis, Acute Fulminating

Expression Detail

GEO ID: GSE140106 Description: Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment Experimental Design: Fingolimod treatment Case Disease Type: Multiple Sclerosis Case Disease SubType: NA Case Sample: Fingolimod treated Multiple Sclerosis Control Sample: Untreated Number of Case: 27 Number of Control: 27 Number of Samples: 54

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand AIF1L chr9 131096476 131123152 + AKT2 chr19 40230317 40285536 - C19orf47 chr19 40319536 40348527 - CDKN1A chr6 36676460 36687339 + F11R chr1 160995211 161021343 - FOXN3 chr14 89124871 89619149 - GATAD2B chr1 153789030 153923360 - GCNT2 chr6 10492223 10629368 + GNPTAB chr12 101745499 101830959 - HMGA2 chr12 65824131 65966295 + ICE1 chr5 5420664 5490220 + JPT1 chr17 75135248 75168281 - LSM14A chr19 34172504 34229515 + MED13L chr12 115953872 116277719 - PRSS16 chr6 27247701 27256624 + SETD7 chr4 139495941 139606699 - SOCS3 chr17 78356778 78360077 - SYNJ2BP chr14 70366499 70417090 - SYNJ2BP-COX16 chr14 70326064 70417074 - ZDHHC6 chr10 112424428 112446917 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001085 chr2 191765289 191789319 + hsa_circ_0001168 chr20 47691321 47707559 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC125257.1 chr17 41848518 41851447 - AC239868.1 chr1 149861271 149862504 + AL034397.3 chrX 66015461 66020422 + AL049795.2 chr1 32170733 32176568 + AL355075.4 chr14 20343048 20343685 - DLEU2 chr13 49956670 50125720 - LINC00641 chr14 21200079 21206900 - NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - OIP5-AS1 chr15 41283990 41309737 + SNHG1 chr11 62851984 62855953 - SNHG16 chr17 76557764 76565348 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE140106 Sample Source: Blood Source Fraction: Exosome Platform: GPL11154 Method: NGS Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1907 Sample treatment protocol: Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). RNA Extract protocol: Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer's protocol. RNA library preparation protocol: Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer's instructions.

Reference

PMID: 31721043 Title: Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment Author: Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F Journal: Mol Neurobiol. 2020 Feb;57(2):1245-1258. Description: we sought the possible utility of serum exosome microRNAs as biomarkers for disease activity in multiple sclerosis patients in response to fingolimod therapy.